Evidence map›Paper›PMID 22634477›Full record

ArticleThe Journal of steroid biochemistry and molecular biology2012

Antiestrogenic activity of flavonoid phytochemicals mediated via the c-Jun N-terminal protein kinase pathway. Cell-type specific regulation of estrogen receptor alpha.

Bridgette M Collins-Burow, James W Antoon, Daniel E Frigo, Steven Elliott, Christopher B Weldon, Stephen M Boue, Barbara S Beckman, Tyler J Curiel, Jawed Alam, John A McLachlan and 1 more

Abstract read
In one paragraph

Article in The Journal of steroid biochemistry and molecular biology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 10 institutions in 1 country.

Bridgette M Collins-BurowTulane University Medical Center, Department of Medicine, Section of Hematology and Medical Oncology, New Orleans, LA 70112, United States.
James W Antoon
Daniel E Frigo
Steven Elliott
Christopher B Weldon
Stephen M Boue
Barbara S Beckman
Tyler J Curiel
Jawed Alam
John A McLachlan
Matthew E Burow
University Hospital and Clinics · USHarvard University · USOchsner Medical Center · USSouthern Regional Research Center · USThe University of Texas Health Science Center at San Antonio · USTulane Medical Center · USTulane University · USUniversity Medical Center · USUniversity of Houston · USXavier University of Louisiana · US

Funding

P13K/AKT crosstalk with ER-signaling and cell survivalR01DK059389 · NIDDK · TULANE UNIVERSITY OF LOUISIANA · PI BUROW, MATTHEW E. · 2003 to 2008
$1.8M
NIDDK NIH HHS DK 059389NIDDK NIH HHS R01 DK059389
6 · The paper itself

Abstract

Flavonoid phytochemicals act as both agonists and antagonists of the human estrogen receptors (ERs). While a number of these compounds act by directly binding to the ER, certain phytochemicals, such as the flavonoid compounds chalcone and flavone, elicit antagonistic effects on estrogen signaling independent of direct receptor binding. Here we demonstrate both chalcone and flavone function as cell type-specific selective ER modulators. In MCF-7 breast carcinoma cells chalcone and flavone suppress ERα activity through stimulation of the stress-activated members of the mitogen-activated protein kinase (MAPK) family: c-Jun N-terminal kinase (JNK)1 and JNK2. The use of dominant-negative mutants of JNK1 or JNK2 in stable transfected cells established that the antiestrogenic effects of chalcone and flavone required intact JNK signaling. We further show that constitutive activation of the JNK pathway partially suppresses estrogen (E2)-mediated gene expression in breast, but not endometrial carcinoma cells. Our results demonstrate a role for stress-activated MAPKs in the cell type-specific regulation of ERα function.

Indexed as

Cell Line, TumorChalconeEstradiolEstrogen Receptor alphaEstrogen Receptor ModulatorsFlavonesHEK293 CellsHumansJNK Mitogen-Activated Protein KinasesChalconeESR1 protein, humanEstradiolEstrogen Receptor alphaEstrogen Receptor ModulatorsflavoneFlavonesJNK Mitogen-Activated Protein Kinases

Identifiers

PMID22634477
PMCPMC4083692
OpenAlexW2007426428

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.